Statins and the COVID-19 Vaccines: a viewpoint

Abstract

The COVID-19 pandemic has caused many scientists to promptly make vaccines against the disease. A large number of people who will receive the vaccines will likely be older adults, many of whom being long-term statin users. Statins, known to be immunomodulators, can interact with vaccines and alter their effects. Whether this effect is significant or not is up for debate, like in the case of the influenza vaccine. Thus, the interaction between statins and the COVID-19 vaccines should be investigated and understood, and guidelines should be written to ensure that the vaccines perform optimally.